"It is not possible to quantify the risks associated with the use of reprocessed single use medical devices". This is the thrust of the European Commission's final report to the European Parliament and European Council following months of study and research into this highly controversial subject1...
Scrip Regulatory Affairs
European Commission report on reuse inconclusive: more evaluation ahead
31 August 2010
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- Industry and European Commission tackle barriers to biosimilars market penetration
- French bill proposes heavy penal sanctions if medtech falls foul of marketing rules
- EU medtech report calls for randomised clinical trials and centralised pre-market evaluation
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
